ALLMedicine™ Hypersensitivity Vasculitis Center
Research & Reviews 21 results
https://emedicine.medscape.com/article/202030-differential
Jul 13th, 2022 - Diagnostic Considerations Other problems to be considered in the differential diagnosis of hypereosinophilic syndrome include the following: Allergic diseases Angiolymphoid hyperplasia with eosinophilia Collagen vascular diseases Atopic dermatitis...
https://doi.org/10.1177/03000605221097768
The Journal of International Medical Research; Almasoudi AA, Bablghaith ES et. al.
May 20th, 2022 - Leukocytoclastic vasculitis (hypersensitivity vasculitis) is defined as small blood vessel inflammation with skin or other systemic manifestations due to infections, drugs, or neoplastic disease. This clinical case report highlights an association...
https://doi.org/10.1016/j.ajem.2020.10.024
The American Journal of Emergency Medicine; Fikse DJ, Grenz PM et. al.
Oct 25th, 2020 - Henoch Schonlein Purpura is a rare hypersensitivity vasculitis that is commonly associated with pediatric patients. It typically presents with purpuric rash to the lower extremities, abdominal pain and microscopic hematuria; however, it may also b...
http://emedicine.medscape.com/article/1083719-overview
Apr 3rd, 2020 - Background Hypersensitivity vasculitis, which is usually represented histopathologically as leukocytoclastic vasculitis (LCV), is a term commonly used to denote a small-vessel vasculitis. There are many potential causes of hypersensitivity vasculi...
https://emedicine.medscape.com/article/1083719-print
Apr 3rd, 2020 - Background Hypersensitivity vasculitis, which is usually represented histopathologically as leukocytoclastic vasculitis (LCV), is a term commonly used to denote a small-vessel vasculitis. There are many potential causes of hypersensitivity vasculi...
Drugs 31 results
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a2a5bb34-671b-499c-b8b4-c40fb51af09a
Feb 2nd, 2023 - Recent Major Changes Section Warnings and Precautions (5) 11/2022 Indications & Usage Section Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin for oral suspension is indicated in the trea...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=554239db-69fe-405a-910a-d9f9e3f8b6ed
Jan 13th, 2023 - Recent Major Changes Section Warnings and Precautions (5) 11/2022 Indications & Usage Section Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin for oral suspension is indicated in the trea...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14a5f8c2-fdaf-4ad4-982b-c5aa128e242d
Jan 12th, 2023 - Recent Major Changes Section Warnings and Precautions (5) 11/2022 Indications & Usage Section Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin for oral suspension is indicated in the trea...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=73219f24-6eac-4472-b2a7-cad36936c185
Jan 12th, 2023 - Indications & Usage Section Amoxicillin capsules are a penicillin-class antibacterial indicated for treatment of infections due to susceptible strains of designated microorganisms. Infections of the ear, nose, throat, genitourinary tract, skin and...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bbe590a0-4196-4885-b679-cc1833af567f
Jan 10th, 2023 - Recent Major Changes Section Warnings and Precautions (5) 11/2022 Indications & Usage Section Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin capsules are indicated in the treatment of ...
News 3 results
https://www.mdedge.com/pediatrics/article/143862/pediatrics/tips-navigating-pityriasis-lichenoides-children
Doug Brunk
Aug 3rd, 2017 - CHICAGO – Pityriasis lichenoides chronica (PLC) is a benign, chronic disorder that can last from 1 to 5 years, yet no formal treatment standards exist. “Topical corticosteroids will not alter the course of the disease, but they provide symptomatic.
https://www.medpagetoday.com/cardiology/atherosclerosis/55492
Jan 3rd, 2016 - Our Year in Review series highlights some of the major medical news stories of 2015. The approval of lipid-lowering biologics that target PCSK9 was one of the year's key events in cardiology. Here is the original article, published July 24. In a c...
https://www.medpagetoday.com/cardiology/atherosclerosis/52770
Jul 24th, 2015 - The FDA granted approval to alirocumab (Praluent) for heterozygous familial hypercholesterolemia (FH) and for patients with clinical atherosclerotic cardiovascular disease, making it the first in the new class of lipid-lowering PCSK9 inhibitors. T...